Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Small Cap Foreign Biotech -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (153)	12/14/2000 12:24:39 PM
From: RWReeves	Read Replies (1) \| Respond to of 363

QLTI taking a beating. Ho hum. Fools rush out where analysts fear to tread... You only need to hear the reverence with which laser jockey ophtalmologists speak of Visudyne to appreciate it. 35 million in sales this Q and 40 million were expected. Terrible thing. Cover me, I'm going in... AXO.T moving again, and time to check in on Biomira also. Lots of interesting talk at ASH about vaccines and antigen processing and presentation. I sold some CLL today that I got in trade for CIST. A good value but there are better to be had in the market. RWR